These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15192172)

  • 1. Genital condylomata in a patient receiving infliximab for Crohn's disease.
    Somasekar A; Alcolado R
    Postgrad Med J; 2004 Jun; 80(944):358-9. PubMed ID: 15192172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab-induced thrombocytopenia in an elderly patient with ileocolonic Crohn's disease.
    Mocciaro F; Russo G; Di Mitri R; Marino A
    Inflamm Bowel Dis; 2013; 19(4):E52-3. PubMed ID: 22535599
    [No Abstract]   [Full Text] [Related]  

  • 3. [Indications and results of infliximab in Crohn's disease].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
    Keating GM; Perry CM
    BioDrugs; 2002; 16(2):111-48. PubMed ID: 11985485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy.
    Dubcenco E; Ottaway CA; Chen DL; Baker JP
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):565-6. PubMed ID: 16607158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
    Seddik M; Meliez H; Seguy D; Viget N; Cortot A; Colombel JF
    Inflamm Bowel Dis; 2004 Jul; 10(4):436-7. PubMed ID: 15475754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary actinomycosis complicating infliximab therapy for Crohn's disease.
    Cohen RD; Bowie WR; Enns R; Flint J; Fitzgerald JM
    Thorax; 2007 Nov; 62(11):1013-4. PubMed ID: 17965080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab for the treatment of Crohn's disease: efficacy, safety and pharmacoeconomics.
    Feagan BG; Enns R; Fedorak RN; Panaccione R; Paré P; Steinhart AH; Wild G
    Can J Clin Pharmacol; 2001; 8(4):188-98. PubMed ID: 11743591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease.
    Panagi S; Palka W; Korelitz BI; Taskin M; Lessnau KD
    Inflamm Bowel Dis; 2004 May; 10(3):274-7. PubMed ID: 15290924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe anaphylactic reaction to infliximab: successful treatment with adalimumab - report of a case.
    Stallmach A; Giese T; Schmidt C; Meuer SC; Zeuzem SS
    Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):627-30. PubMed ID: 15167167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pneumocystis pneumonia during infliximab treatment for active Crohn's colitis].
    Minnee RC; Stokkers P; Riemens SC; Hommes DW
    Ned Tijdschr Geneeskd; 2005 Oct; 149(41):2290-5. PubMed ID: 16240855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety aspects of infliximab in inflammatory bowel disease patients. A retrospective cohort study in 100 patients of a German University Hospital.
    Seiderer J; Göke B; Ochsenkühn T
    Digestion; 2004; 70(1):3-9. PubMed ID: 15297773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab in the surgical management of complex fistulating anal Crohn's disease.
    Talbot C; Sagar PM; Johnston MJ; Finan PJ; Burke D
    Colorectal Dis; 2005 Mar; 7(2):164-8. PubMed ID: 15720356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonist.
    Angelucci E; Cocco A; Viscido A; Vernia P; Caprilli R
    Inflamm Bowel Dis; 2007 Aug; 13(8):1059-61. PubMed ID: 17387676
    [No Abstract]   [Full Text] [Related]  

  • 15. [Listeria meningitis as complication of treatment with infliximab in a patient with Crohn's disease].
    Osuna Molina R; Ferrer Ríos T; Gallego Gallegos R; Ramos Lora M; Ynfante Ferrús M; Figueruela López B
    Rev Esp Enferm Dig; 2006 Jan; 98(1):60-1. PubMed ID: 16555939
    [No Abstract]   [Full Text] [Related]  

  • 16. [Systemic candidiasis and infliximab therapy].
    Belda A; Hinojosa J; Serra B; García L; Merino C; Belda A; Molés JR
    Gastroenterol Hepatol; 2004; 27(6):365-7. PubMed ID: 15207136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab therapy in a patient with Crohn's disease and chronic hepatitis B virus infection.
    del Valle García-Sánchez M; Gómez-Camacho F; Poyato-González A; Iglesias-Flores EM; de Dios-Vega JF; Sancho-Zapatero R
    Inflamm Bowel Dis; 2004 Sep; 10(5):701-2. PubMed ID: 15472541
    [No Abstract]   [Full Text] [Related]  

  • 18. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab.
    Martínez F; Nos P; Benlloch S; Ponce J
    Inflamm Bowel Dis; 2001 Nov; 7(4):323-6. PubMed ID: 11720323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab treatment for Crohn's disease.
    Conroy CA; Cattell R
    Postgrad Med J; 2001 Jul; 77(909):436-40. PubMed ID: 11423591
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous nevi pigmentosus during infliximab therapy in a patient with Crohn's disease: fallacy or coincidence?
    Katsanos KH; Christodoulou DK; Zioga A; Tsianos EV
    Inflamm Bowel Dis; 2003 Jul; 9(4):279. PubMed ID: 12902853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.